High-dose chemotherapy with autologous stem cell transplantation is feasible and safe in a regional hospital. A 6-year experience in southern Switzerland

Bone Marrow Transplantation

Volumn 19, Issue 1, 1997, Pages 3-7

  Regazzoni, S ^a   Marini, G ^b   Grob, A ^b   Pedrazzini, A ^b   Goldhirsch, A ^b   Castelli, D ^a   Cavalli, F ^b   Ghielmini, M ^b  

^a Ctro Trasfusionale Regionale C   (Switzerland)

^b OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

High dose therapy; Lymphoma; Peripheral hospital; Stem cell transplantation

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GROWTH FACTOR; MELPHALAN; MITOXANTRONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD COMPONENT; BLOOD TRANSFUSION; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; LENGTH OF STAY; LEUKEMIA; LYMPHOMA; MALE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SEPSIS; STEM CELL TRANSPLANTATION; SWITZERLAND; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0031033228     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700610     Document Type: Article

References (21)

1. Coiffier B, Philip T, Burnett AK, Symann ML. Consensus Conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol 1994; 12: 226-231.
2. Peterson BA. The role of transplantation in non-Hodgkin's lymphoma. J Clin Oncol 1994: 12: 2524-2526.
3. Bierman J, Vose JM, Armitage JO. Autologous transplantation for Hodgkin's disease: coming of age? Blood 1994; 83: 1161-1164.
4. Petersen FB, Lynch MHE, Clift RA et al. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission. J Clin Oncol 1993; 11: 1353-1360.
5. Siegert W, Beyer J, Strohscheer I et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. J Clin Oncol 1994; 12: 1223-1231.
6. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
7. Coutinho LH, Gilleece MH, De Wynter EA et al. Clonal and long-term cultures using human bone marrow. In: Testa NG, Molineux G (eds). Haemopoiesis. A Practical Approach. Oxford University Press: New York, 1993, pp 75-105.
8. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
9. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986; 105: 429-435.
10. Chopra R, McMillan AK, Linch DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood 1993; 81: 1137-1145.
11. Carey PJ, Proctor SJ, Taylor P et al. Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. Blood 1991; 77: 1593-1598.
12. Gianni AM, Siena S, Bregni M et al. Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease. Ann Oncol 1991; 2: 645-653.
13. Santos GW. The development of busulfan/cyclophosphamide preparative regimens. Semin Oncol 1993; 20: 12-16.
14. Davis JM, Rowley SD, Braine HG et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990; 75: 781-786.
15. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
16. Peters WP, Rosner G, Ross M et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemoterapy. Blood 1993; 81: 1709-1719.
17. Pettengell R, Morgenstern GR, Woll PJ et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 82: 3770-3777.
18. Klumpp TR. Complications of peripheral blood stem cell transplantation. Semin Oncol 1995; 22: 263-270.
19. Russell JA, Poon MC, Jones AR et al. Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease. Lancet 1992; 339: 38-40.
20. Weaver CH, Petersen FB, Appelbaum FR et al. High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. J Clin Oncol 1994; 12: 2559-2566.
21. Horning SJ, Negrin RS, Chao NJ et al. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 2552-2558.